Shlomo Shalev

Shlomo Spokone Shalev currently works at XTL Biopharmaceuticals Ltd., as Chairman from 2025, G.F.C Green Fields Capital Ltd., as Chairman from 2015, Tree Tube Ltd., as Chairman from 2019, Arel Communications & Software Ltd., as Director, Regenera Pharma Ltd., as Director, SaverOne 2014 Ltd., as Independent External Director from 2020, and Gadin Holdings Ltd., as Director.
Mr. Shalev also formerly worked at InterCure Ltd., as Chairman from 2015 to 2018, Jeen Technologies AI Ltd., as Chairman from 2007 to 2014, PowerDsine Ltd., as Director, Ophir Optronics Ltd., as Director, Smart Link Ltd., as Director, Netformx, Inc., as Director, IXI Mobile, Inc., as Director from 2007 to 2008, Fore Biotherapeutics, Inc., as Director, Ampal-American Israel Corp., as Senior Vice President-Investments, and Government of Israel, as Consul-Economic Affairs from 1994 to 1997.
Mr. Shalev received his Masters Business Admin degree from the University of San Francisco and undergraduate degree from Ben-Gurion University of the Negev.